Ratings Banca Mediolanum S.p.A.

Equities

BMED

IT0004776628

Market Closed - Borsa Italiana 11:44:59 2024-04-26 am EDT 5-day change 1st Jan Change
10.03 EUR +1.16% Intraday chart for Banca Mediolanum S.p.A. -1.38% +17.53%

Summary

  • The company has a good ESG score relative to its sector, according to Refinitiv.

Strengths

  • Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
  • Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • The company's attractive earnings multiples are brought to light by a P/E ratio at 9.62 for the current year.
  • The company has a low valuation given the cash flows generated by its activity.
  • The company is one of the best yield companies with high dividend expectations.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • Over the past four months, analysts' average price target has been revised upwards significantly.
  • Considering the small differences between the analysts' various estimates, the group's business visibility is good.
  • Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
  • The group usually releases upbeat results with huge surprise rates.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Banks

1st Jan change Capi. Investor Rating ESG Refinitiv
+17.53% 7.94B
A-
+13.75% 556B
C+
+12.36% 298B
C+
+8.64% 247B
C+
+21.72% 210B
C
+16.11% 170B
B-
+6.88% 162B
B-
+4.42% 153B
C+
-11.67% 138B
B-
+0.10% 139B
B-
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. BMED Stock
  4. Ratings Banca Mediolanum S.p.A.